January 22-24 | Irvine, CA | DTA Reimbursement Intensive Workshop | Ticketed
This 40 person workshop will provide a comprehensive understanding and strategy framework for the key payor landscapes for digital therapeutics, including government, commercial, employer, and direct-to-consumer models.
You’ll explore the latest trends and challenges in securing reimbursement from Medicare, Medicaid, VA, and commercial payors, and gain insight into the pathways for inpatient, outpatient, and durable medical equipment services.
_______________________________________________________________________________________________________________
January 28 at 1:00PM ET | Mapping the Patient Odyssey for DTx | Free
Digital Therapeutics (DTx) offer innovative solutions to improve patient health, but successful adoption requires a deep understanding of the patient journey. This webinar introduces a Patient Odyssey resource, designed to help DTx companies navigate the complexities of engaging patients at every stage of their healthcare experience.
_______________________________________________________________________________________________________________
February 5 at 2:00PM Singapore / 1:00AM ET | Exploring Regulatory and Reimbursement Pathways for DTx: Asia Pacific | Free
Join us for a webinar series where we delve into the complexities of regulatory and reimbursement pathways for digital therapeutics around the globe. Each session in this series will focus on a specific country or region, providing a comprehensive overview of the landscape for digital therapeutics.
In this session, we will focus on a specific the Asia-Pacific region, providing a comprehensive overview of the regulatory and reimbursement frameworks for digital therapeutics. We will review the frameworks in countries including South Korea, Japan, China, Singapore, and Australia.
_______________________________________________________________________________________________________________
February 11 at 11:00AM ET | Digital Therapeutics in 2025: How U.S. Administration Changes Could Impact DTx | Members Only
As a new U.S. Administration takes office and control of the U.S. House and Senate shifts with narrow GOP majorities, digital therapeutics companies and investors are preparing for anticipated changes in the federal regulatory, compliance, policy, and legislative arenas. Join us to learn more about this changed landscape and what it means for the digital therapeutics field in 2025 and beyond.
If you are a member interested in attending this event, please contact Stephanie.
_______________________________________________________________________________________________________________
February 26 at 10:00AM ET | DTx Dialogue: CE Essentials for DTx: Everything You Need for European Success | Free
Join our webinar to master the essentials of navigating the European regulatory ecosystem for DTx! Discover the key steps to obtain CE marking for Digital Therapeutics from Class I andabove. Whether you’re starting from scratch or building on an FDA clearance, this webinar will be educational for all levels. Through French and German examples, we’ll explore the regulatory journey and its challenges.